Citations for
1CCND1, tCEAL7
Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.
Orhan C, Bulut P, Dalay N, Ersen E, Buyru N.
Mol Biol Rep 46(5):5251-5256. doi: 10.1007/s11033-019-04982-6. Epub 2019 Jul 18. 2019
2CCND1, CDK4, SHCBP1
SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD, Yuan YL, Yu HB, Tian GJ, Li DY.
Oncol Rep Mar;41(3):1649-1657. doi: 10.3892/or.2018.6952. Epub 2018 Dec 21 2018
3CCND1, CCNE1, CDK2, CDK4, CIAPIN1
The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.
Huang Z, Su GF, Hu WJ, Bi XX, Zhang L, Wan G.
Eur Rev Med Pharmacol Sci 21(13):3054-3060. 2017
4CCND1, MYF5
Novel RNA-binding activity of MYF5 enhances Ccnd1/Cyclin D1 mRNA translation during myogenesis.
Panda AC, Abdelmohsen K, Martindale JL, Di Germanio C, Yang X, Grammatikakis I, Noh JH, Zhang Y, Lehrmann E, Dudekula DB, De S, Becker KG, White EJ, Wilson GM, de Cabo R, Gorospe M.
Nucleic Acids Res 44(5):2393-408. doi: 10.1093/nar/gkw023. Epub 2016 Jan 26. 2016
5CCND1, CDC42BPA
Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
Masamha CP, Albrecht TR, Wagner EJ.
J Hematol Oncol 9:30. doi: 10.1186/s13045-016-0260-7. 2016
6CCND1, CLDN16, CPE, LRP1B, MAGI3, MAPK6, MATN2, MPPED2, PFKFB2, PTPRE, PYGL, SEMA3D, SERGEF, SLC4A4, TIMP1
robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers
Gomez-Rueda H, Palacios-Corona R, Gutiérrez-Hermosillo H, Trevino V. A
Int J Mol Med. May;37(5):1355-62. doi: 10.3892/ijmm.2016.2534. Epub 2016 Mar 2016
7CCND1, CCND3, CCNG1, HNRNPM, IGF2BP3
Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization.
Rivera Vargas T, Boudoukha S, Simon A, Souidi M, Cuvellier S, Pinna G, Polesskaya A.
Oncogene 33(22):2866-75. doi: 10.1038/onc.2013.252. Epub 2013 Jul 1. 2014
8CCND1, CCNE1, CSF2
GM-CSF induces cyclin D1 expression and proliferation of endothelial progenitor cells via PI3K and MAPK signaling.
Qiu C, Xie Q, Zhang D, Chen Q, Hu J, Xu L.
Cell Physiol Biochem 33(3):784-95. doi: 10.1159/000358652. Epub 2014 Mar 7. 2014
9BCL2A1, CCND1
Up-regulation of cyclinD1 and Bcl2A1 by insulin is involved in osteoclast proliferation.
Lee JY, Lee NK.
Life Sci. Oct 2;114(2):57-61. doi: 10.1016/j.lfs.2014.07.006. Epub 2014 Jul 24 2014
10CCND1
Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y, Fukumoto M.
Cell Cycle 12(5). [Epub ahead of print] 2013
11BIRC5, CCND1, POU5F1
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.
Cao L, Li C, Shen S, Yan Y, Ji W, Wang J, Qian H, Jiang X, Li Z, Wu M, Zhang Y, Su C.
BMC Cancer 13:82. doi: 10.1186/1471-2407-13-82. 2013
12CCND1, PCNA, ROCK1, ROCK2
Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through ERK and induction of cyclin D1 and PCNA.
Zhao Y, Lv M, Lin H, Cui Y, Wei X, Qin Y, Kohama K, Gao Y.
Biochem Biophys Res Commun 432(3):488-93. doi: 10.1016/j.bbrc.2013.02.009. Epub 2013 Feb 10. 2013
13CCND1, CDK4, STK38, STK38L
Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
Du Z, Tong X, Ye X.
J Biol Chem 288(37):26678-87. doi: 10.1074/jbc.M113.466433. Epub 2013 Jul 29. 2013
14CCND1, CCNE1, KDM5A
Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis.
Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY, Lin FM, Huang HD, Chen YT, Jeng YM, Hsu CH, Yan Q, Tsai MD, Juan LJ.
Cancer Res 73(15):4711-21. doi: 10.1158/0008-5472.CAN-12-3165. Epub 2013 May 30. 2013
15CCND1, EYA1
EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.
Wu K, Li Z, Cai S, Tian L, Chen K, Wang J, Hu J, Sun Y, Li X, Ertel A, Pestell RG.
Cancer Res 73(14):4488-99. doi: 10.1158/0008-5472.CAN-12-4078. Epub 2013 May 1. 2013
16CASP3, CCND1, MMP9, NUMBL, TRAF6
Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell.
Yingjie L, Jian T, Changhai Y, Jingbo L.
Tumour Biol 34(5):2773-80. doi: 10.1007/s13277-013-0835-7. Epub 2013 May 17. 2013
17CARD10, CCND1
CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression.
Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, Xu H.
Biochem Biophys Res Commun 425(4):781-7. doi: 10.1016/j.bbrc.2012.07.152. Epub 2012 Aug 2. 2012
18CCND1, MLXIPL
Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.
Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, Towle HC, Chau AT, Albrecht JH.
Cell Cycle 11(14):2681-90. doi: 10.4161/cc.21019. Epub 2012 Jul 15. 2012
19CCND1, CDK4, YY1
Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1.
Ishii H, Hulett MD, Li JM, Santiago FS, Parish CR, Khachigian LM.
Int J Oncol 40(5):1575-80. doi: 10.3892/ijo.2012.1362. Epub 2012 Feb 9. 2012
20CCND1, ISG15, USP18
Evidence for the ubiquitin protease UBP43 as an antineoplastic target.
Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E.
Mol Cancer Ther 11(9):1968-77. doi: 10.1158/1535-7163.MCT-12-0248. Epub 2012 Jul 2. 2012
21CCND1, JUN, PAX2
PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.
Zhang HS, Yan B, Li XB, Fan L, Zhang YF, Wu GH, Li M, Fang J.
J Biol Chem 287(53):44164-72. doi: 10.1074/jbc.M112.401521. Epub 2012 Nov 7. 2012
22CCND1, CIRBP, DYRK1B, RBM3
Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice.
Masuda T, Itoh K, Higashitsuji H, Higashitsuji H, Nakazawa N, Sakurai T, Liu Y, Tokuchi H, Fujita T, Zhao Y, Nishiyama H, Tanaka T, Fukumoto M, Ikawa M, Okabe M, Fujita J.
Proc Natl Acad Sci U S A 109(27):10885-90. doi: 10.1073/pnas.1121524109. Epub 2012 Jun 18. 2012
23CCND1, FAM60A, HDAC1, SIN3A
Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.
Muñoz IM, MacArtney T, Sanchez-Pulido L, Ponting CP, Rocha S, Rouse J.
J Biol Chem 287(39):32346-53. 2012
24CCND1, PACSIN2
PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.
Meng H, Tian L, Zhou J, Li Z, Jiao X, Li WW, Plomann M, Xu Z, Lisanti MP, Wang C, Pestell RG.
Cell Cycle 10(1):73-81. Epub 2011 Jan 1. 2011
25CCND1, SSB
The RNA-binding protein La contributes to cell proliferation and CCND1 expression.
Sommer G, Dittmann J, Kuehnert J, Reumann K, Schwartz PE, Will H, Coulter BL, Smith MT, Heise T.
Oncogene 30(4):434-44. Epub 2010 Sep 20. 2011
26CCND1, SNAI2, UBE2D3
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.
Mittal MK, Singh K, Misra S, Chaudhuri G.
J Biol Chem 286(1):469-79. Epub 2010 Nov 2. 2011
27CCND1
Cyclin D1 inhibits mitochondrial activity in B cells.
Tchakarska G, Roussel M, Troussard X, Sola B.
Cancer Res 71(5):1690-9. Epub 2011 Feb 22. 2011
28CCND1, CDK4
Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma.
Ciznadija D, Liu Y, Pyonteck SM, Holland EC, Koff A.
Cancer Res 71(19):6174-83. doi: 10.1158/0008-5472.CAN-11-1031. Epub 2011 Aug 15. 2011
29CCND1
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.
Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P.
Nature 474(7350):230-4. doi: 10.1038/nature10155. 2011
30CCND1, PPFIA1
PPFIA1 and CCND1 are frequently coamplified in breast cancer.
Dancau AM, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wencke K, Monni O, Simon R.
Genes Chromosomes Cancer 49(1):1-8.PMID: 19787783 2010
31CCND1, RUNX3
Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
Iwatani K, Fujimoto T, Ito T.
Biochem Biophys Res Commun 400(3):426-31. Epub 2010 Aug 27. 2010
32CCND1, CDC27
C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.
Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E.
Proc Natl Acad Sci U S A 107(20):9210-5. doi: 10.1073/pnas.0913813107. Epub 2010 May 3. 2010
33ATM, CCND1
ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation.
Choo DW, Baek HJ, Motoyama N, Cho KH, Kim HS, Kim SS.
Biochem Biophys Res Commun 378(4):847-50. Epub 2008 Dec 9. 2009
34CCND1
Overrepresentation of BclI polymorphism of the glucocorticoid receptor gene in pregnant women with HELLP syndrome.
Bertalan R, Patocs A, Nagy B, Derzsy Z, Gullai N, Szappanos A, Rigo J Jr, Racz K.
Clin Chim Acta lin Chim Acta. 2009 Mar 28. [Epub ahead of print] 2009
35CCND1, INSM1
Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
Zhang T, Liu WD, Saunee NA, Breslin MB, Lan MS.
J Biol Chem 284(9):5574-81. Epub 2009 Jan 5. 2009
36CCND1
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES.
Oncogene 28(15):1812-20. Epub 2009 Mar 16. 2009
37FHL2, CCND1
The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.
Labalette C, Nou‘t Y, Sobczak-Thepot J, Armengol C, Levillayer F, Gendron MC, Renard CA, Regnault B, Chen J, Buendia MA, Wei Y.
J Biol Chem 283(22):15201-8. Epub 2008 Mar 31. 2008
38CCND1, CCND2, CCND3
Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T, Naito K, Osada S, Nishizuka M, Imagawa M.
Biochem Biophys Res Commun 370(2):289-94. Epub 2008 Mar 27. 2008
39CCND1, MEN1
Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
Yi Y, Nowak NJ, Pacchia AL, Morrison C.
Genes Chromosomes Cancer 47(8):639-48. 2008
40CCND1
Cyclin D1 in low-dose radiation-induced adaptive resistance.
Ahmed KM, Fan M, Nantajit D, Cao N, Li JJ.
Oncogene 27(53):6738-48. Epub 2008 Aug 11. 2008
41CCND1
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.
Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES.
Cancer Res 68(14):5628-38. 2008
42CCND1, VRK1
VRK1 phosphorylates CREB and mediates CCND1 expression.
Kang TH, Park DY, Kim W, Kim KT.
J Cell Sci 121(Pt 18):3035-41. Epub 2008 Aug 19. 2008
43BRAF, CCND1
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P.
J Clin Invest 118(5):1739-49.PMID: 18398503 2008
44CCND1
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.
Blood 109(11):4599-606. Epub 2007 Feb 13. 2007
45CCND1, RNF14
ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
Kikuchi H, Uchida C, Hattori T, Isobe T, Hiramatsu Y, Kitagawa K, Oda T, Konno H, Kitagawa M.
Carcinogenesis 28(8):1752-8. Epub 2007 May 17. 2007
46CCND1, ORAOV1, CTTN, SHANK2, FGF3
Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S.
Genes Chromosomes Cancer 45(2):118-25. 2006
47PTEN, CCND1
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation.
Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C.
Hum Mol Genet 15(17):2553-9. Epub 2006 Jul 18. 2006
48CCND1
Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC, Kaur P, Kaur S, Singh J, Janmeja AK, Jindal SK, Kishan J, Raimondi S.
Cancer Genet Cytogenet 170(2):108-14. 2006
49CCND1
Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
Jhang JS, Narayan G, Murty VV, Mansukhani MM.
Cancer Genet Cytogenet 149(2):114-9. 2004
50SNIP1, CCND1
The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression.
Roche KC, Wiechens N, Owen-Hughes T, Perkins ND.
Oncogene 23(50):8185-95. 2004
51PTTG1, CCND1
Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability.
Liu B, Liang MH, Kuo YL, Liao W, Boros I, Kleinberger T, Blancato J, Giam CZ.
Mol Cell Biol 23(15):5269-81. 2003
52CCND1
Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, Hardisson D, Sarrio D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J.
Oncogene 22(38):6115-8. 2003
53CCND1
Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene.
Gruszka-Westwood AM, Atkinson S, Summersgill BM, Shipley J, Elnenaei MO, Jain P, Hamoudi RA, Kaeda JS, Wotherspoon AC, Matutes E, Catovsky D.
Genes Chromosomes Cancer 33(2):206-12. 2002
54CCND1, CCNE1
Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E.
Duman-Scheel M, Weng L, Xin S, Du W.
Nature 417(6886):299-304. 2002
55CCND1
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J.
Int J Oncol 20(1):45-52. 2002
56CCND1, PAX5, TAL1
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.
Falini B, Mason DY.
Blood 99(2):409-26. Review. 2002
57CCND1
Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
Jin Y, Jin C, Wennerberg J, Hoglund M, Mertens F.
Int J Cancer 98(3):475-9. 2002
58CCND1, CDH1
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER.
Oncogene 21(12):1928-33. 2002
59CCND1, TACSTD2
Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells.
Terrinoni A, Dell'Arciprete R, Fornaro M, Stella M, Alberti S.
Genes Chromosomes Cancer 31(3):209-20. 2001
60CCND1
CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.
Bala S, Peltomaki P.
Cancer Res 61(16):6042-5. 2001
61BCL2, CCNA1, CCNB1, CCND1, CDKN1A, CDKN2A, MKI67, RB1
Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
Kanavaros P, Stefanaki K, Rontogianni D, Papalazarou D, Sgantzos M, Arvanitis D, Vamvouka C, Gorgoulis V, Siatitsas I, Agnantis NJ, Bai M.
Histol Histopathol 16(4):1005-12. 2001
62CCND1, JUN, JUNB
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.
Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M.
EMBO J 19(9):2056-68. 2000
63CCND1
Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.
Beier F, et al.
Proc Natl Acad Sci U S A 96 : 1433-1438. 1999
64CCND1
Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
Matsumura I, et al.
EMBO J 18(5):1367-1377. 1999
65CCND1, RB1
Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y, et al.
Kidney Int 55(4):1375-83. 1999
66CCND1, CCND2, CCND3
Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
Buschges R, et al.
Brain Pathol 9(3):435-42; discussion 432-3 1999
67BCL1, CCND1
Cooperative and differential effects of estrogen, prolactin, 22K and 20K human growth hormones on cyclin D1/PRAD1 gene expression in T-47D human breast cancer cells.
Kaneko H, Fujikawa T, Alam KS, Kaneko S, Tanaka M, Hibasami H, Nakashima K.
Biochem Mol Biol Int 46 : 411-414. 1998
68BCL1, CCND1
Detection of cyclin D1 (bcl-1), PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
Uchimaru K, et al.
Blood 89 : 965-974. 1997
69BCL1, CCND1
Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization.
de Boer CJ, Vaandrager JW, van Krieken JH, Holmes Z, Kluin PM, Schuuring E.
Oncogene 15(13):1599-603. 1997
70CCND1, CTTN, FGF3
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL.
Oncogene 15(13):1617-23. 1997
71BCL1, CCND1
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
De Boer CJ, et al.
Oncogene 10 : 1833-1840. 1995
72CDKN2A, RB1, CCND1
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J, et al.
Nature 375 : 503-506. 1995
73CCND1, CTTN
The involvement of the chromosome 11q13 region in human malignancies : cyclin D1 and EMS1 are two new candidate oncogenes-a review.
Schuuring E.
Gene 159 : 83-96. 1995
74CCND1
A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl DE, et al.
Oncogene 9 : 1925-1929. 1994
75BCL1, CCND1
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.
Rimokh R, et al.
Blood 83 : 3689-3696. 1994
76BCL1, CCND1
Identification of a B lymphoid disorder defined by specific morphologic features, a del(11)(q13) and a same breakpoint far from CCND1. (abstr)
Morel D, et al.
Am J Hum Genet 55 : A301. 1994
77BCL1, CCND1
A variant chromosome translocation at 11q13 identifying PRAD1/Cyclin D1 as the BCL-1 gene.
Komatsu H, et al.
Blood 84 : 1226-1231. 1994
78BCL1, CCND1
Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
Galigue-Zouitina S, et al.
Genes Chromosomes Cancer 11 : 246-255. 1994
79BCL1, CCND1
Chromosome t(11;14)(q13;32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.
Williams ME, et al.
Leukemia 7 : 1437-1440. 1993
80CCND1
PRADI/cyclin DI proto-oncogene : genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
Motokura T, et al.
Genes Chromosomes Cancer 7 : 89-95. 1993
81CCND1, BCL1
Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams ME, et al.
Leukemia 7 : 241-245. 1993
82CTTN, CCND1
Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Schuuring E, et al.
Oncogene 7 : 355-361. 1992
83CCND1, CCND2, CCND3, CCND2P, CCND3P
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes.
Inaba T, et al.
Genomics 13 : 565-574. 1992
84CCND1
Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
Seto M, et al.
Oncogene 7 : 1401-1406. 1992
85CCND1
A novel cyclin encoded by a bcl1-linked candidate oncogene.
Motokura T, et al.
Nature 350 : 512-515. 1991
86CCND1
Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in begnin parathyroid tumors.
Rosenberg CL, et al.
Oncogene 6 : 449-453. 1991
87CCND1
D11S287, a putative oncogene on chromosome 11q13,is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA, et al.
Oncogene 6 : 439-444. 1991
88CCND1
HaeIII polymorphism within 3' untranslated region of PRAD1.
Heighway J.
Nucleic Acids Res 19 : 5451. 1991
89CCND1, BCL1
PRAD1, a candidate BCL1 oncogene : mapping and expression in centrocytic lymphoma.
Rosenberg CL, et al.
Proc Natl Acad Sci U S A 88 : 9638-9642. 1991
90BCL1, CCND1
Human D-type cyclin.
Xiong Y, et al.
Cell 65 : 691-699. 1991
91CCND1
Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
Arnold A, et al.
J Clin Invest 83 : 2034-2040. 1989